XML 81 R56.htm IDEA: XBRL DOCUMENT v3.24.1
LICENSE AGREEMENTS (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Nov. 30, 2021
Sep. 30, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Provision for foreign income taxes     $ 1,100  
Repayments of debt     1,716    
Agreement with Newsoara Bio Pharma Co Ltd [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Up-front and near-term payments   $ 9,900      
Additional product payments   160,500      
Proceeds from license fees received       $ 5,400 $ 4,500
Income tax rate       10.00% 10.00%
Royalty expense     5,000    
Primary performance obligation   $ 6,000      
Related revenue       $ 11,000  
Provision for foreign income taxes       1,100  
Repayments of debt       9,900  
Agreement with Newsoara Bio Pharma Co Ltd [Member] | State Administration of Taxation, China [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Income tax rate   10.00%      
Agreement with ELIAS Animal Health LLC [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Proceeds from license fees received $ 60        
Royalty expense     $ 60    
Related revenue       68  
Repayments of debt       60  
Revenue performance obligation, amount       60  
Agreement with ELIAS Animal Health LLC [Member] | Manufacturing Facility [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revenue performance obligation, amount       $ 8